The Hyperlipidemia Caused by Overuse of Glucocorticoid after Liver Transplantation and the Immune Adjustment Strategy

The overuse of glucocorticoid may cause the metabolic disorders affecting the long term outcome of liver transplantation. This study aims to investigate the immune adjustment strategy by decreasing use of glucocorticoid after liver transplantation. The follow-up study was carried out on liver functi...

Full description

Saved in:
Bibliographic Details
Main Authors: Xueqin Meng, Xinhua Chen, Liming Wu, Shusen Zheng
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2017/3149426
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832566620339306496
author Xueqin Meng
Xinhua Chen
Liming Wu
Shusen Zheng
author_facet Xueqin Meng
Xinhua Chen
Liming Wu
Shusen Zheng
author_sort Xueqin Meng
collection DOAJ
description The overuse of glucocorticoid may cause the metabolic disorders affecting the long term outcome of liver transplantation. This study aims to investigate the immune adjustment strategy by decreasing use of glucocorticoid after liver transplantation. The follow-up study was carried out on liver function and lipid metabolism. This study included adult recipients of liver transplantation. There were 3 groups according to their use of glucocorticoid: long term (>3 months, n=18), short term (<3 months, n=20), and control group (no use of glucocorticoid, radical hepatic resection, n=22). The laboratory results of liver function (AST/ALT ratio) and serum lipid were compared 6 months after liver transplantation. AST/ALT ratio, the marker of liver function, showed no significant difference between long and short term group (P>0.05). The acute rejection had no significant difference between short and long term groups, while TG, HDL, LDL, and glucose showed significant change in the long term group (P<0.05). At 6 months after liver transplantation, the long term group showed higher metabolic disorders (P<0.05). The proper immune adjustment strategy should be made to avoid overuse of glucocorticoid. It can decrease hyperlipidemia and other metabolic disorders after liver transplantation without increasing the acute rejection or liver function damage.
format Article
id doaj-art-6c342c6421854a24ab3710b7748a351e
institution Kabale University
issn 2314-8861
2314-7156
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-6c342c6421854a24ab3710b7748a351e2025-02-03T01:03:36ZengWileyJournal of Immunology Research2314-88612314-71562017-01-01201710.1155/2017/31494263149426The Hyperlipidemia Caused by Overuse of Glucocorticoid after Liver Transplantation and the Immune Adjustment StrategyXueqin Meng0Xinhua Chen1Liming Wu2Shusen Zheng3Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University, Hangzhou 310003, ChinaCollaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University, Hangzhou 310003, ChinaCollaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University, Hangzhou 310003, ChinaCollaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University, Hangzhou 310003, ChinaThe overuse of glucocorticoid may cause the metabolic disorders affecting the long term outcome of liver transplantation. This study aims to investigate the immune adjustment strategy by decreasing use of glucocorticoid after liver transplantation. The follow-up study was carried out on liver function and lipid metabolism. This study included adult recipients of liver transplantation. There were 3 groups according to their use of glucocorticoid: long term (>3 months, n=18), short term (<3 months, n=20), and control group (no use of glucocorticoid, radical hepatic resection, n=22). The laboratory results of liver function (AST/ALT ratio) and serum lipid were compared 6 months after liver transplantation. AST/ALT ratio, the marker of liver function, showed no significant difference between long and short term group (P>0.05). The acute rejection had no significant difference between short and long term groups, while TG, HDL, LDL, and glucose showed significant change in the long term group (P<0.05). At 6 months after liver transplantation, the long term group showed higher metabolic disorders (P<0.05). The proper immune adjustment strategy should be made to avoid overuse of glucocorticoid. It can decrease hyperlipidemia and other metabolic disorders after liver transplantation without increasing the acute rejection or liver function damage.http://dx.doi.org/10.1155/2017/3149426
spellingShingle Xueqin Meng
Xinhua Chen
Liming Wu
Shusen Zheng
The Hyperlipidemia Caused by Overuse of Glucocorticoid after Liver Transplantation and the Immune Adjustment Strategy
Journal of Immunology Research
title The Hyperlipidemia Caused by Overuse of Glucocorticoid after Liver Transplantation and the Immune Adjustment Strategy
title_full The Hyperlipidemia Caused by Overuse of Glucocorticoid after Liver Transplantation and the Immune Adjustment Strategy
title_fullStr The Hyperlipidemia Caused by Overuse of Glucocorticoid after Liver Transplantation and the Immune Adjustment Strategy
title_full_unstemmed The Hyperlipidemia Caused by Overuse of Glucocorticoid after Liver Transplantation and the Immune Adjustment Strategy
title_short The Hyperlipidemia Caused by Overuse of Glucocorticoid after Liver Transplantation and the Immune Adjustment Strategy
title_sort hyperlipidemia caused by overuse of glucocorticoid after liver transplantation and the immune adjustment strategy
url http://dx.doi.org/10.1155/2017/3149426
work_keys_str_mv AT xueqinmeng thehyperlipidemiacausedbyoveruseofglucocorticoidafterlivertransplantationandtheimmuneadjustmentstrategy
AT xinhuachen thehyperlipidemiacausedbyoveruseofglucocorticoidafterlivertransplantationandtheimmuneadjustmentstrategy
AT limingwu thehyperlipidemiacausedbyoveruseofglucocorticoidafterlivertransplantationandtheimmuneadjustmentstrategy
AT shusenzheng thehyperlipidemiacausedbyoveruseofglucocorticoidafterlivertransplantationandtheimmuneadjustmentstrategy
AT xueqinmeng hyperlipidemiacausedbyoveruseofglucocorticoidafterlivertransplantationandtheimmuneadjustmentstrategy
AT xinhuachen hyperlipidemiacausedbyoveruseofglucocorticoidafterlivertransplantationandtheimmuneadjustmentstrategy
AT limingwu hyperlipidemiacausedbyoveruseofglucocorticoidafterlivertransplantationandtheimmuneadjustmentstrategy
AT shusenzheng hyperlipidemiacausedbyoveruseofglucocorticoidafterlivertransplantationandtheimmuneadjustmentstrategy